Latest filing published 17 Nov 2017 for NEKTAR THERAPEUTICS, €188k.
Filing timeline
BuySaleInsider track record
Ivan P. Gergel: trading record in brief
This profile gathers the share dealings of Ivan P. Gergel across 3 companies, led by Endo Pharmaceuticals Holdings Inc, Nektar Therapeutics and Endo International plc. The record holds 75 filings, for trades running from 26 February 2009 to 16 November 2017.
The open-market record consists of 25 sales worth €14.9M, with no purchase. Other entries cover 20 share grants and 22 option exercises. In 2017 alone, the filings show no purchases and 8 sales.
The latest filing, published on 17 November 2017, reports a transaction of €188k in Nektar Therapeutics. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. For comparison, the SEC allows two business days to file a Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Ivan P. Gergel
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 5,022 shares@ US$44.233.1% of flowCommon StockSEC:0001209191-17-061590:1
- 20,000 shares0Common StockSEC:0001209191-17-061590:0
- 43,296 shares@ US$11.046.6% of flowCommon StockSEC:0001209191-17-055353:0
- 43,296 shares@ US$24.0414.5% of flowCommon StockSEC:0001209191-17-055353:1
- 56,704 shares@ US$11.048.7% of flowCommon StockSEC:0001209191-17-055353:2
- 56,704 shares@ US$24.2119.2% of flowCommon StockSEC:0001209191-17-055353:3
- 1,997 shares@ US$19.320.5% of flowCommon StockSEC:0001209191-17-049664:0
- 54,920 shares@ US$11.048.6% of flowCommon StockSEC:0001209191-17-045842:0
- 54,920 shares@ US$21.1016.4% of flowCommon StockSEC:0001209191-17-045842:1
- 8,389 shares@ US$11.041.3% of flowCommon StockSEC:0001209191-17-045121:0
- 36,691 shares@ US$11.045.8% of flowCommon StockSEC:0001209191-17-045121:2
- 36,691 shares@ US$21.0911.1% of flowCommon StockSEC:0001209191-17-045121:3
- 8,389 shares@ US$21.042.5% of flowCommon StockSEC:0001209191-17-045121:1
- 1,450 shares@ US$19.550.4% of flowCommon StockSEC:0001209191-17-033766:0
- 1,457 shares@ US$13.140.3% of flowCommon StockSEC:0001209191-17-012403:0
- 20,000 shares0Common StockSEC:0001209191-16-155517:0
- 848 shares@ US$13.960.2% of flowCommon StockSEC:0001209191-16-151301:0
- 1,685 shares@ US$17.560.4% of flowCommon StockSEC:0001209191-16-137608:0
- 15,000 shares0Common StockSEC:0001209191-16-133053:0
- 1,250 shares0Common StockSEC:0001209191-16-121346:0
- 432 shares@ US$13.580.1% of flowCommon StockSEC:0001209191-16-121346:1
- 1,250 shares0Common StockSEC:0001209191-16-100222:0
- 556 shares@ US$11.920.1% of flowCommon StockSEC:0001209191-16-100222:1
- 15,742 shares@ US$20.61Ordinary SharesSEC:0001209191-14-019571:0
- 15,742 shares@ US$72.47Ordinary SharesSEC:0001209191-14-019571:1
25 of 75 declarations
